Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.

Boston Scientific has shared a range of data highlighting the benefits of spinal cord stimulation (SCS) therapies within its ...

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...

According to a detailed report by the BBC, growing scientific evidence suggests that hypnosis can deliver real clinical benefits, sometimes outperforming conventional treatments in effectiveness, cost ...

Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here ...

By Mariam Sunny and Mrinalika Roy Jan 15 (Reuters) - Boston Scientific on Thursday agreed to buy medtech firm Penumbra in a ...

Angelo De Rosa (left) will succeed the retiring Scott Olson (right) as president of the Boston Scientific CRMDx business. [Images from LinkedIn] Boston Scientific (NYSE: BSX) + will have a transition ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific has been ...

Recent analysis highlights how Boston Scientific’s acquisition strategy is a primary engine for growth. It strengthens its core business while expanding into adjacent high-growth markets. The company ...

Boston Scientific bought its newly opened 400,000 sq. ft. Maple Grove facility from Ryan Cos. for $188.8 million. The office pricing sits at $472 per square foot, among the highest in years The site ...